AFP and neoplasm: An orthotopic HCC xenograft model was employed to test in vivo the efficacy of a lypopoliplex (LPP)-let-7c formulation, displaying a significant reduction of tumor burden associated with decreased AFP serum levels and increased apoptotic markers.